Molecular Biomarkers of Primary and Acquired Resistance to T‐Cell‐Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions

The emergence of immunotherapy has revolutionized cancer treatment in recent years. Inhibitors of immune checkpoints, including antibodies against cytotoxic T‐lymphocyte‐associated protein 4, programmed cell death protein 1, and programmed death ligand 1, have demonstrated notable efficacy in certai...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncologist
Huvudupphovsmän: Chae, Young Kwang, Oh, Michael S., Giles, Francis J.
Materialtyp: Artigo
Språk:Inglês
Publicerad: AlphaMed Press 2017
Ämnen:
Cancer Diagnostics and Molecular Pathology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5896702/
https://ncbi.nlm.nih.gov/pubmed/29242279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0354
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk